 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Committee Hearing The House Committee on Energy and Commerce An Inquiry into the ImClone Cancer-Drug Story
Subcommittee on Oversight and Investigations
Connect to the archive of this hearing webcast.
The free Real Player basic is required in order to connect to this broadcast. Witness
List & Prepared Testimony
Panel 1 Dr. Frank PapineauDetailee Committee on Energy and Commerce 2125 Rayburn House Office Building Washington, DC, 20515 Accompanied By: Dr. Raymond Weiss, M.D., F.A.C.P. Consultant in Oncology Clinical Professor of Medicine Lombardi Cancer Center Georgetown University Medical Center Washington, D.C. Panel 2 Dr. Samuel WaksalFormer Chief Executive Officer ImClone Systems, Inc 180 Varick Street New York, NY, 10014 Dr. Harlan Waksal Chief Executive Officer ImClone Systems, Inc. 180 Varick Street New York, NY, 10014 Dr. Laurie Smaldone M.D. Senior Vice President Global Regulatory Sciences Bristol-Myers Squibb Company Route 206 & Provinceline Road A13-09 Princeton, NJ, 08546 Accompanied By: Mr. Brian Markison Vice PresidentDivision of Oncology Bristol-Myers Squibb Company Panel 3 Dr. Patricia Keegan M.D.Deputy Division Director Center for Biologics Evaluation and Research Office of Therapeutic Research and Review Division of Clinical Trials Design and Analysis U.S. Food & Drug Administration 1401 Rockville Pike, HFM-573 Rockville, MD, 20852 Dr. Richard Pazdur M.D., F.A.C.P. Director Division of Oncology Drug Products Office of Drug Evaluation I Center for Drug Evaluation and Research U.S. Food & Drug Administration 5600 Fishers Lane, HFD-150 Rockville, MD, 20857 Dr. Lee H. Pai-Scherf Dr. M.D. Medical Officer, Clinical Reviewer Center for Biologics Evaluation and Research Office of Therapeutic Research and Review Division of Clinical Trials Design and Analysis Oncology Branch U.S. Food & Drug Administration 1401 Rockville Pike, HFM-573 Rockville, MD, 20852 Dr. George Q. Mills M.D., M.B.A Acting Chief, Team Leader Center for Biologics Evaluation and Research Office of Therapeutic Research and Review Division of Clinical Trials Design and Analysis Oncology Branch U.S. Food & Drug Administration 1401 Rockville Pike, HFM-573 Rockville, MD, 20852 Dr. Susan M. Jerian M.D. Medical Officer, Team Leader Center for Biologics Evaluation and Research Division of Clinical Trials Design and Analysis Oncology Branch U.S. Food & Drug Administration 1401 Rockville Pike, HFM-573 Rockville, MD, 20852 Hearing Transcript: Not Available The transcript of this hearing should be available within 60-90 days of the conclusion of the hearing. Click here for the latest list of available hearing transcripts..
Other Released Hearing Documents An Inquiry Into The Imclone Cancer-Drug Matter Preliminary Committee Staff Report Report
to House Committee on Energy and Commerce
Document Menu Printed
Hearing Record |
|||||||||||
|
